
浏览全部资源
扫码关注微信
1.400037 重庆,陆军军医大学(第三军医大学)第二附属医院血液病医学中心,全军血液病中心,创伤、烧伤与复合伤国家重点实验室
2.563099 贵州 遵义,遵义医科大学第二附属医院检验科
3.400038 重庆,陆军军医大学(第三军医大学)基础医学院细胞生物学教研室
[张曦,E-mail: zhangxxi@sina.com ZHANG Xi, E-mail: zhangxxi@sina.com
收稿:2021-08-10,
修回:2021-09-05,
纸质出版:2021-11-15
移动端阅览
王蔚浩, 杨世杰, 杜雨軒, 等. 皮肤优势型慢性移植物抗宿主病小鼠模型的构建[J]. 第三军医大学学报, 2021,43(21):2286-2293.
Weihao WANG, Shijie YANG, Yuxuan DU, et al. Establishment of a mouse model of skin-dominant chronic graft-versus-host disease[J]. Journal of Third Military Medical University, 2021, 43(21): 2286-2293.
王蔚浩, 杨世杰, 杜雨軒, 等. 皮肤优势型慢性移植物抗宿主病小鼠模型的构建[J]. 第三军医大学学报, 2021,43(21):2286-2293. DOI: 10.16016/j.1000-5404.202108060.
Weihao WANG, Shijie YANG, Yuxuan DU, et al. Establishment of a mouse model of skin-dominant chronic graft-versus-host disease[J]. Journal of Third Military Medical University, 2021, 43(21): 2286-2293. DOI: 10.16016/j.1000-5404.202108060.
目的
2
构建皮肤优势型慢性移植物抗宿主病(chronic graft-versus-host disease
cGVHD)小鼠模型。
方法
2
利用致死剂量辐照BALB/c小鼠,并接受来自B10.D2供鼠混合的骨髓细胞和脾脏细胞以构建皮肤优势型cGVHD小鼠模型,通过小鼠临床表现、病理特征及靶器官细胞亚群评估模型构建情况。
结果
2
模型小鼠的临床表现以皮肤脱毛、硬化、皮屑、结痂和由皮肤皱缩硬化引起的弓背和关节僵直为主,临床病理评分随疾病进展升高,但无明显肠道cGVHD表现。病理改变中皮肤出现明显胶原沉积,毛囊减少甚至消失,而其他靶器官病理改变不明显。对以上靶器官行T细胞亚群分析,发现Th1细胞、CD4
+
IL-13
+
T细胞和Tc1细胞与疾病进展密切。
结论
2
成功构建可用于实验研究的皮肤优势型小鼠cGVHD模型,病理变化主要以皮肤纤维化表现为主。
Objective
2
To construct a mouse model of skin-dominant chronic graft-versus-host disease (cGVHD).
Methods
2
BALB/c mice were irradiated with lethal dose and then received a mixture of bone marrow and spleen cells transplantation from B10.D2 donor mice. Then the clinical manifestations
pathological features of the mice and cell subsets of targeted organs were observed to evaluate the establishment of model.
Results
2
The clinical manifestations of the model mice mainly involved skin depilation
sclerosis
dandruff
scab
as well as arched back and joint stiffness due to skin shrinkage and
sclerosis. The clinicopathological scores were increased with the progression of cGVHD
while the model mice showed no obvious manifestations of intestinal cGVHD. Moreover
increase of collagen deposition and decrease or even disappearance of hair follicles was observed on the histopathologic sections of skin
while other targeted organs showed no major alterations. T cell subsets analysis indicated that Th1 cells
CD4
+
IL-13
+
T cells and Tc1 cells were closely related to the disease progression.
Conclusion
2
The skin-dominant cGVHD mouse model is successfully established
with skin damage and fibrosis as main pathological changes.
KRÖGER N. Preventing graft-versus-host disease without losing graft-versus-leukemia effect after allogeneic stem-cell transplantation[J]. J Clin Oncol, 2020, 38(29): 3357-3360. DOI: 10.1200/jco.20.01756.
中华医学会血液学分会造血干细胞应用学组, 中国抗癌协会血液病转化委员会. 慢性移植物抗宿主病(cGVHD)诊断与治疗中国专家共识(2021年版)[J]. 中华血液学杂志, 2021, 42(4): 265-275.
Applied Hematopoietic Stem Cell Group of Hematology Branch of Chinese Medical Association, Hematological Diseases Transformation Committee of Chinese Anti-Cancer Society. Chinese expert consensus on diagnosis and treatment of chronic graft-versus-host disease (cGVHD) (2021 edition)[J]. Chin J Hematol, 2021, 42(4): 265-275.
陈婷, 李小平, 高强国, 等. 不同方法检测急性移植物抗宿主病患者的血清标志物[J]. 第三军医大学学报, 2019, 41(23): 2280-2284. DOI: 10.16016/j.1000-5404.201907252.
CHEN T, LI X P, GAO Q G, et al . Different methods for detecting serum markers in patients with acute graft versus host disease[J ] . J Third Mil Med Univ, 2019, 41(23): 2280-2284. DOI: 10.16016/j.1000-5404.201907252.
HOGENES M C H, VAN DORP S, VAN KUIK J, et al . Modifying graft-versus-host disease in a humanized mouse model by targeting macrophages or B-cells[J ] . J Immunol Res, 2019, 2019: 3538963. DOI: 10.1155/2019/3538963.
YE Y, RICARD L, STOCKER N, et al . A novel mouse model of acute graft-versus-host disease based on chemotherapy conditioning and G-CSF mobilized graft[J ] . Bone Marrow Transplant, 2020, 55(3): 570-577. DOI: 10.1038/s41409-019-0700-4.
MVLLER A M S, MIN D, WERNIG G, et al . Modeling chronic graft-versus-host disease in MHC-matched mouse strains: genetics, graft composition, and tissue targets[J ] . Biol Blood Marrow Transplant, 2019, 25(12): 2338-2349. DOI: 10.1016/j.bbmt.2019.08.001.
SCHROEDER M A, DIPERSIO J F. Mouse models of graft-versus-host disease: advances and limitations[J]. Dis Model Mech, 2011, 4(3): 318-333. DOI: 10.1242/dmm.006668.
BOIERI M, SHAH P, JALAPOTHU D, et al . Rat acute GvHD is Th1 driven and characterized by predominant donor CD4 + T-cell infiltration of skin and gut[J ] . Exp Hematol, 2017, 50: 33-45. e3. DOI: 10.1016/j.exphem.2017.02.002..
MALARD F, BOSSARD C, ARBEZ J, et al . Plasmacytoid dendritic cells (PDC) and Th17 immune response contribution in gut acute graft-versus-host-disease (GVHD)[J ] . Blood, 2011, 118(21): 2968. DOI: 10.1182/blood.V118.21.2968.2968.
GUO L Y, LAI P L, WANG Y L, et al . Extracellular vesicles derived from mesenchymal stem cells prevent skin fibrosis in the cGVHD mouse model by suppressing the activation of macrophages and B cells immune response[J ] . Int Immunopharmacol, 2020, 84: 106541. DOI: 10.1016/j.intimp.2020.106541.
KAPLAN D H, ANDERSON B E, MCNIFF J M, et al . Target antigens determine graft-versus-host disease phenotype[J ] . J Immunol, 2004, 173(9): 5467-5475. DOI: 10.4049/jimmunol.173.9.5467.
PAN B, WANG D, LI L, et al . IL-22 accelerates Thymus regeneration via Stat3/mcl-1 and decreases chronic graft-versus-host disease in mice after allotransplants[J ] . Biol Blood Marrow Transplant, 2019, 25(10): 1911-1919. DOI: 10.1016/j.bbmt.2019.06.002.
FURUE K, ITO T, TSUJI G, et al . The IL-13-OVOL1-FLG axis in atopic dermatitis[J ] . Immunology, 2019, 158(4): 281-286. DOI: 10.1111/imm.13120.
BODOOR K, AL-QARQAZ F, HEIS L A, et al . IL-33/13 axis and IL-4/31 axis play distinct roles in inflammatory process and itch in psoriasis and atopic dermatitis[J ] . Clin Cosmet Investig Dermatol, 2020, 13: 419-424. DOI: 10.2147/ccid.s257647.
ODAK I, DEPKAT-JAKOB A, BECK M, et al . Donor-derived IL-17A and IL-17F deficiency triggers Th1 allo-responses and increases gut leakage during acute GVHD[J ] . PLoS ONE, 2020, 15(4): e0231222. DOI: 10.1371/journal.pone.0231222.
MORIN F, KAVIAN N, MARUT W, et al . Inhibition of EGFR tyrosine kinase by erlotinib prevents sclerodermatous graft-versus-host disease in a mouse model[J ] . J Invest Dermatol, 2015, 135(10): 2385-2393. DOI: 10.1038/jid.2015.174.
YEH S P, LIAO Y M, LO W J, et al . Kinetics of T helper subsets and associated cytokines correlate well with the clinical activity of graft-versus-host disease[J ] . PLoS ONE, 2012, 7(9): e44416. DOI: 10.1371/journal.pone.0044416.
TAWARA I, NIEVES E, LIU C, et al . Host basophils are dispensable for induction of donor T helper 2 cell differentiation and severity of experimental graft-versus-host disease[J ] . Biol Blood Marrow Transplant, 2011, 17(12): 1747-1753. DOI: 10.1016/j.bbmt.2011.08.013.
LEE G R. The balance of Th17 versus treg cells in autoimmunity[J]. Int J Mol Sci, 2018, 19(3): 730. DOI: 10.3390/ijms19030730.
YASUDA K, TAKEUCHI Y, HIROTA K. The pathogenicity of Th17 cells in autoimmune diseases[J]. Semin Immunopathol, 2019, 41(3): 283-297. DOI: 10.1007/s00281-019-00733-8.
DELENS L, EHX G, SOMJA J, et al . In vitro Th17-polarized human CD4 + T cells exacerbate xenogeneic graft-versus-host disease[J ] . Biol Blood Marrow Transplant, 2019, 25(2): 204-215. DOI: 10.1016/j.bbmt.2018.10.007..
GUTIÉRREZ-HOYA A, LÓPEZ-SANTIAGO R, VELA-OJEDA J, et al . Role of CD8 regulatory T cells versus Tc1 and Tc17 cells in the development of human graft-versus-host disease[J ] . J Immunol Res, 2017, 2017: 1236219. DOI: 10.1155/2017/1236219.
CHASSET F, LE BUANEC H, SICRE DE FONTBRUNE F, et al . Evidence of Th1, Th17 and Tc17 cells in psoriasiform chronic graft-versus-host disease[J ] . Exp Dermatol, 2016, 25(1): 64-65. DOI:10.1111/exd.12857.
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621